(Nasdaq: HOLX), a global leader in women’s health, today announced the launch of Ultimate Defense, a new educational campaign ...

What Hologic’s recent performance could mean for investors Hologic (HOLX) has been drawing fresh attention after a mix of ...

Shares of Hologic HOLX closed the first trading session of the year at $74.56, which is quite close to the 52-week high of $75.34, reached on Dec. 15, 2025. In the past six months, the company has ...

Women’s health tech company Hologic is launching "Better is Possible," a new health education and awareness campaign aimed at getting women to talk to their doctors about their disruptive period ...

Fintel reports that on January 12, 2026, Argus Research downgraded their outlook for Hologic (NasdaqGS:HOLX) from Buy to Hold ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

Powerful artificial intelligence combined with digital imaging designed to transform screening Genius™ Digital Diagnostics System for Cervical Cancer Screening (Photo: Business Wire) For more than 30 ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today launched Project Health Equality (PHE), a unique initiative that strives to address the ...

Though the vast majority of women are aware of the importance of early screening for various cancers and other life-threatening health conditions, a new survey estimates that nearly half of those in ...

After reaping a windfall from COVID-19 diagnostic demand, Hologic’s spending spree continues with its largest acquisition yet: It’s claimed Mobidiag, the Finnish-French molecular test maker, with a ...

Hologic stock (NASDAQ: HOLX) has rallied around 83% over recent weeks (vs. about a 40% gain in the S&P 500) to its current level of $53 after falling to a low of $29 in late March as a rapid increase ...